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Health Status, Medicare Part D Enrollment, and
Prescription Drug Use Among Older Adults
Jin Kim
Northeastern Illinois University
To account for potential selection factors in the observed relationship between Medicare Part D coverage and prescription drug use,
this study uses data from the 2010 and 2012 waves of the Health
and Retirement Study (HRS) to first examine the determinants of
Medicare Part D enrollment, paying particular attention to the role
of functional health status on the enrollment decision. Next, the
study assesses whether and to what extent Medicare Part D coverage moderates the effect of functional health status on prescription
drug use and monthly out-of-pocket spending among older adults.
As prior studies indicate, the findings reveal that individuals who
take up Medicare Part D have poorer (functional) health relative
to nonparticipants, and thus, exhibit greater demand for prescription drugs. Taking functional health status into account, Medicare
Part D coverage is significantly associated with greater prescription drug use among those with few health limitations, and is also
significantly associated with greater out-of-pocket spending among
those with the most health limitations. Thus, while prior studies
have compared Medicare eligible- to non-eligible individuals to
find that Medicare Part D coverage significantly lowers out-ofpocket costs, and therefore, increases prescription drug use, this
study compared Medicare Part D enrollees to eligible non-enrollees
to generate findings that imply that the presumed effect of Medicare Part D coverage on prescription drug use may be spurious. In
turn, advocacy efforts may be best directed at ensuring that the existing coverage gaps in Medicare Part D are continually addressed.
Key words: health insurance, access to and utilization of services,
health care policy

In the current climate of massive health care reform in
the U.S., older adults potentially enjoy greater access to
both prescription drug insurance and to use of prescription
drugs. Before health care reform, however, access to both
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prescription drug insurance and medications was not so
readily available. Researchers estimate that just prior to implementation of the Medicare prescription drug benefit program
(Medicare Part D), approximately one quarter of individuals
age 65 and over lacked prescription drug insurance coverage (Levy & Weir, 2009). Meanwhile, prescription drug use
among older adults had been steadily increasing even before
passage and implementation of the Medicare Part D program.
According to estimates released by the Center for Disease
Control, the rate of prescription drug use among individuals
65 years and over (i.e., the percent of individuals with at least
one prescription drug in the past 30 days) had increased from
73.6% in 1994 to 84.7% by the year 2002 (Center for Disease
Control, 2014).
Generally speaking, health service use, including the use of
prescription drugs, should increase with greater health insurance coverage (Hurd & McGarry, 1997). So the increase in prescription drug use prior to implementation of Medicare Part
D in 2006 may have reflected a combination of greater private
insurance coverage, along with other factors such as a sicker
older adult population, improvements in medicine, and/or
more effective marketing by pharmaceutical companies.
Nevertheless, Congress responded to the lack of prescription drug insurance coverage (along with the increased demand
for prescription drugs) among older adults by passing the
Medicare Prescription Drug Improvement and Modernization
Act, which established and implemented the Medicare Part
D program effective January 1, 2006 to increase access to prescription drugs among older adults (House Committee on
Ways and Means, 2014). With the new program in place, the
vast majority of eligible retirees were now covered under some
form of prescription drug insurance plan. Thus, by 2010, 89.7%
of all individuals 65 years and over reported using prescription drugs (Center for Disease Control, 2014).
Prior research on the impact of the Medicare prescription
drug benefit program on prescription drug use among older
adults has found that Medicare Part D initially lowered outof-pocket costs and therefore increased overall use in the early
years of the program (Lichtenberg & Sun, 2007; Yin, Basu,
Zhang, Rabbani, Meltzer, & Alexander, 2008). These studies
generally rely on quasi-experimental designs to compare
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out-of-pocket costs and rates of use between Medicare Part D
eligible- and non-eligible individuals to show that there was
indeed a program effect.
What is not entirely clear from the favorable findings generated by these studies, however, is whether the observed relationship between Medicare Part D coverage and prescription
drug use and costs is attributable to potential selection factors
that may be confounded for a program effect. To wit, studies
examining the factors associated with the initial decision to
enroll in Medicare Part D find that Part D enrollees are sicker,
are more likely to use prescription drugs, and have higher outof-pocket spending than those who remain without any prescription drug insurance coverage (Levy & Weir, 2010). Stated
differently, the findings suggest selection into Part D that is
based almost entirely on health status and use of prescription
drugs (Levy & Weir, 2010).
To account for these potential selection factors in the observed relationship between Medicare Part D coverage and
prescription drug use, this study uses data from the 2010 and
2012 waves of the Health and Retirement Study (HRS) to first
examine the determinants of Medicare Part D enrollment,
paying particular attention to the role of functional health
status on the enrollment decision. Next, the study assesses
whether and to what extent Medicare Part D coverage moderates the effect of health status on prescription drug use and
monthly out-of-pocket spending among older adults.
Studies assessing the impact of public programs on health
service use are especially important in the current climate
of U.S. health care reform, as they provide evidence (or lack
thereof) of the extent to which our public policies are effectuating the legislative goals of our new public health care
system. With this in mind, the current research extends prior
work on the topic by explicitly taking into account possible
selection factors that may be interacting with program effects.
Moreover, the research uses the most recently available data
from a nationally representative sample of older adults, and
thus updates prior work that had relied on regional pharmacy
chain data. And in lieu of a quasi-experimental design, this research uses multivariate analyses to first identify the ways in
which Medicare Part D enrollees are systematically different,
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if at all, from non-enrollees, and second, to assess the extent to
which the presumed effect of Medicare Part D differs across
varying levels of functional health.

The Literature and Conceptual Framework
Most studies that examine the determinants of health
service use among older adults are framed around the
Andersen Model (1968) which originally describes three sets
of factors that predict health service use: predisposing characteristics, enabling resources, and need. Predisposing factors
include basic socio-demographic characteristics such as age,
gender, race/ethnicity, and marital status. Enabling factors
include both personal and community-level resources such as
income, health insurance, and the availability of health personnel and facilities. Need refers to both perceived and evaluated
need, that is, the individual’s perception of care requirements
and professional judgment about the individual’s health status
and his or her need for medical care (Andersen, 1995). In short,
the model suggests that people’s use of health services is a
function of their predisposition to use services, factors which
enable or impede use, and their need for care (Andersen, 1995).
A major goal of the Andersen Model, as originally conceived,
was to provide measures of access to medical care (Andersen,
1995). Equitable access then, according to Andersen, occurs
when demographic and need variables account for most of the
variance in utilization (1995). As such, the Andersen Model is a
useful framework not only to organize potential explanations
for prescription drug use but also to gauge potential inadequacies and inequities in access to prescription drug use.
Of particular interest in this research are factors related
to need and enabling resources, and more specifically, functional limitations and Medicare prescription drug insurance
coverage. Need is a dimension that has arguably been overlooked in prior research on prescription drug use among
older adults, primarily due to the use of quasi-experimental
designs that focus specifically on the enabling dimension, i.e.,
the treatment effects of Medicare prescription drug insurance
coverage (Lichtenberg & Sun, 2007; Yin et al., 2008). In the
broader context of health service use, however, need, i.e., perceived, diagnosed, and functional health status, represents a
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potentially powerful selection factor that may be relevant in
the use of health services, including prescription drugs (Hurd
& McGarry, 1997). Need is also important to consider since it
implicates the issue of equity in access to health services and
prescription drugs (Anderson, 1995).
While the dimension of need may have previously taken
on a secondary focus to the effect of enabling resources, i.e.,
prescription drug insurance coverage, in the context of policy
studies on prescription drug use, it has nevertheless been recognized as a significant, contributing factor in other relevant
contexts (Levy & Weir, 2010). In Levy and Weir (2010), the
researchers used data from the 2002 through the 2006 waves
of the Health and Retirement Study to estimate a model of
Medicare Part D enrollment among those with no prior drug
coverage and found that demand for prescription drugs, as
measured by the number of diagnosed health conditions, was
the most important determinant of the decision to enroll in the
program. Stated differently, what this study showed was that
Medicare Part D enrollees are sicker than those who do not
enroll, thus suggesting that in the realm of access to health insurance, those who may need prescription drugs the most do
appear to have access to Medicare prescription drug insurance
coverage.
Meanwhile, studies examining the association between enabling resources and the use of prescription drugs have made
a strong case for the favorable impact of prescription drug
insurance coverage on prescription drug use (Lichtenberg
& Sun, 2007; Yin et al., 2008). In one study investigating the
effect of the Medicare Part D prescription drug benefit on drug
utilization and expenditures (Yin et al., 2008), the researchers
estimated prescription utilization and out-of-pocket expenditures attributable to Part D among a sample of persons eligible
for the benefit, and found that average monthly drug utilization increased 5.9 percent and out-of-pocket expenditures decreased by 13.1 percent. In another recent study examining the
impact of Medicare Part D coverage on prescription drug use
by older adults (Lichtenberg & Sun, 2007), the researchers used
a difference-in-differences research design and estimated that
Medicare Part D reduced user cost among older adults by 18.4
percent and increased prescription drug use by 12.8 percent.
In using quasi-experimental designs, these two studies
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follow in the tradition of the RAND Health Insurance
Experiment which randomly assigned individuals to health
insurance plans that varied in deductibles and co-payments
and found that those with the largest cost-sharing had significantly lower health expenditures relative to those with no
cost-sharing (Newhouse, 1993). The main difference, however,
between the Rand experiment and more recent studies examining the impact of Medicare prescription drug insurance coverage is that the latter studies did not randomly assign sample
members into treatment and control conditions, but rather
compared elderly to non-elderly (i.e., Part D eligible to noneligible) individuals.
While comparing eligible to non-eligible persons may be
a conventional method of assessing the impact of public programs on health service use (see Cutler & Gruber, 1996; Card &
Shore-Sheppard, 2004), in the absence of random assignment,
such a comparison may be vulnerable to confounding factors,
most notably in the form of selection effects or systematic differences between treatment and comparison groups that may
be mistaken for a program effect.
Thus, to account for the possibility that the established
relationship between Medicare Part D coverage and prescription drug use among older adults may be due to selection
factors, this study first examines the determinants of Medicare
Part D enrollment with an eye towards identifying systematic
differences between Medicare Part D participants and nonparticipants. Under the expectation that Medicare Part D participants are indeed sicker than non-participants, the study
then assesses whether and to what extent Medicare Part D
coverage moderates the effect of health status on prescription
drug use and costs. More specifically, the study uses the wellestablished Katz index of Activities of Daily Living (ADL) to
create three separate categories of functional health status to
determine whether the effect of Medicare Part coverage differs
across these three varying levels of functional health (Katz,
Ford, Moskowitz, Jackson, & Jaffe, 1963; Katz, Downs, Cash,
& Grotz, 1970).

Data and Methods
Data come from the Health and Retirement Study (HRS),
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a nationally representative panel study of persons age 50 and
over and their spouses. Section N of the HRS survey, in particular, elicits detailed information about respondents’ prescription drug insurance coverage, prescription drug use, outof-pocket expenses, and health conditions requiring the use of
prescription drugs, and is thus well-suited for a study estimating the effects of health status and prescription drug insurance
coverage on prescription drug use. The full HRS consists of
six cohorts representing persons born before 1960 in the U.S.,
including those born between 1942 and 1947, i.e., the War Baby
(WB) cohort.
The sample is drawn from the 2010 and 2012 waves of
the HRS to make use of the most recently available data on
Medicare Part D coverage. To ensure that all sample members
are eligible for enrollment and use of Medicare Part D, the
study draws individuals 65 years and over from the 2010 wave
who report Medicare coverage in both 2010 and 2012. The HRS
includes 8,985 individuals who satisfy these criteria. Baseline
data on sample members are collected for 2010, while outcome
data (i.e., Part D enrollment, and prescription drug use and
out-of-pocket expenses) are collected for 2012. Any sample
member with missing baseline or outcome data is dropped
from the analysis. Thus, the final sample to be used for the
analysis of Part D enrollment includes 8,456 individuals who
are eligible to enroll in Medicare Part D, while the sample to
be used for the analysis of prescription drug costs includes a
subset of 6,316 individuals who report non-zero out-of-pocket
spending on prescription drugs.
Key Measures
This research focuses on three main outcomes: Medicare
Part D enrollment, prescription drug use, and monthly outof-pocket expenses incurred in purchasing prescription drugs.
Constructing an appropriate measure of Medicare Part D enrollment or coverage can be complicated, because individuals covered under Medicare Advantage may report coverage under Part D as well. With this in mind, there are at least
seven different types of prescription drug insurance options
that may be examined: Medicare Part D, Medicaid, Medicare
Advantage, Medigap, employer coverage, other drug coverage, and no coverage. Medicare Advantage, Medigap, and
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other drug coverage are collapsed into one insurance category
for analysis.
The key outcome data for this study come from Section N
of the 2012 HRS, which contains detailed questions on both
public and private health insurance coverage that can be used
to construct the prescription drug insurance options outlined
above. In the beginning of this section, the HRS asks respondents a series of straightforward questions regarding public
health insurance coverage. Individuals are asked whether they
signed up for Medicare prescription drug coverage, whether
they are currently covered under Medicaid, whether they
receive their Medicare benefits through a Health Maintenance
Organization (HMO), and whether the HMO covers or provides help with paying for prescription drugs. While the coding
for the first two questions would seem straightforward, if a
sample member reports that they receive their Medicare benefits through an HMO and that the HMO covers prescription
drugs, then the individual is coded as being covered under a
Medicare Advantage plan.
With respect to private prescription drug insurance coverage, this later section of the survey asks respondents to identify up to three private insurance plans that provide health insurance coverage, whether the private plan in question helps
pay for prescription drugs, and where the respondent purchased the private plan. If a sample member reports that an
identified private plan helps pay for prescription drugs and
that the individual did not purchase the private plan directly
from an insurance company, then the individual is coded as
having employer coverage. If the respondent reports that an
identified private plan helps pay for prescription drugs and
that the individual purchased the private plan directly from
an insurance company, then the individual is coded as having
Medigap coverage.
Towards the end of Section N, respondents who report
taking prescription medications regularly are asked whether
the costs of their prescription medications have been completely covered, mostly covered, only partially covered, or
not covered at all by insurance. Sample members who are not
covered under any of the aforementioned types of prescription
drug insurance, but who report that their prescription drugs
are at least partially covered are coded as having other drug
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coverage. And finally, those individuals not reporting any of
the aforementioned types of coverage are coded as having no
coverage.
In the second part of the analysis, the two main outcome
variables capture whether or not an individual regularly uses
prescription drugs and the logarithm of monthly out-of-pocket expenses incurred in purchasing prescription drugs. This
focus on utilization and (log) expenses, respectively, is consistent with prior studies on health service utilization that often
employ a two-part model—one model to predict the probability or likelihood of any use, and a second model to predict
the level of use (Diehr, 1999; also see Hurd & McGarry, 1997).
In the sample, 90.9% report that they take prescription drugs
regularly and 75.3% report that they incurred monthly out-ofpocket expenses for prescription drugs. Only those reporting
out-of-pocket expenses (i.e., the 75.3%) are included in the final
analysis of monthly out-of-pocket costs.
Another critical piece of the final analytical model is the
measure of functional health status, i.e., the Katz ADL index,
which reports the number of difficulties with six activities of
daily living (e.g., bathing, eating, dressing, grooming, getting
in and out of bed, and using the toilet). Based on this index,
this research classifies sample members into three mutually
exclusive and exhaustive groups: those with 0 ADL difficulties, those with 1 or 2 ADL difficulties, and those with 3 or
more ADL difficulties. The use of the Katz index as a measure
of health status is justified in the health and disability policy
literature as being less susceptible to measurement and endogeneity problems (see Bound, Schoenbaum, Stinebrickner, &
Waidmann, 1999) as well as for its clinical usefulness (see Katz
et al., 1970).
This study also incorporates additional relevant factors
regarding health needs, economic access, and predisposing
characteristics that are aligned with Andersen’s conceptual
framework outlined above. Also subsumed under the category of health needs are a series of dummy variables indicating
whether a doctor diagnosed the respondent as having a particular condition in the 2010 Wave. The eight included conditions
are high blood pressure, diabetes, cancer, lung disease, heart
disease, stroke, psychiatric issues, or arthritis in the current
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wave. The economic access category includes information on
family income (i.e., income less than or equal to 100% of the
federal poverty line (FPL); income 101% to 200% of the FPL;
and income greater than 200% of the FPL) and education (high
school education or GED versus no high school education or
GED). Finally, predisposing factors include dummy variables
on gender (female versus not female), ethnicity (Hispanic
versus not Hispanic), race (Black versus not Black), marital
status (married or partnered versus not married or partnered),
and a categorical age variable (65 to 74; 75 to 84; and 85 and
older).
Using the key variables constructed and prepared for analysis along with the aforementioned health, economic access,
and predisposing variables, the analysis begins with a logistic
regression model of Medicare Part D enrollment, paying particular attention to the role of health needs. This first model
only includes individuals who report no health insurance
coverage in 2010, and is used to account for potential selection factors in the previously observed relationship between
Medicare Part D coverage and prescription drug use. In the
second part of the analysis, a logistic regression model is used
to assess the determinants of prescription drug use while an
ordinary least squares (OLS) regression is used to assess the
determinants of monthly prescription drug expenses. In both
the analysis of Medicare Part D enrollment and the analysis of
prescription drug use and costs, the sample weights that are
provided in the HRS tracker file are used to control for possible
design effects.
While the research is fairly well established in asserting
that Medicare Part D lowered out-of-pocket expenses and increased prescription drug use at least in the fledgling years of
the program, what is less clear is whether the favorable effect
of Medicare Part D coverage holds regardless of an individual’s health status. Thus, this study uses interaction terms to
investigate the possibility that the effect of Medicare prescription drug insurance may not be the same across different levels
of functional health.
As such, the expectation is that Medicare Part D coverage
should lower monthly out-of-pocket spending on prescription
drugs and therefore increase prescription drug use, particularly among older adults with the poorest functional health.
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Table 1. Logistic regression coefficients, standard errors, and exp(B)
for Medicare Part D enrollment
Medicare Part D Enrollment
B(SE)

Exp(B)

-

-

1.228(.453)***

3.416

-0.134(.891)

0.875

High blood pressure

0.192(.222)

1.211

Diabetes

-0.169(.435)

0.844

Cancer

-0.725(.575)

0.484

Lung disease

-0.080(.416)

0.923

Heart disease

0.647(.279)**

1.910

Stroke

0.117(.416)

1.124

Psychiatric

0.112(.348)

1.118

Arthritis

-0.501(.323)

0.606

0% to 100% of FPL

0.956(.522)*

2.601

101% to 200% of FPL

-0.385(.452)

0.681

-

-

-0.569(.402)

0.566

Female

0.209(.382)

1.232

Hispanic

0.055(.691)

1.056

Black

0.375(.499)

1.454

Married or partnered

0.307(.409)

1.359

-

-

75 to 84 years

-0.049(.409)

0.953

85 years and over

-0.127(.560)

0.881

-2.131(.622)

0.119

Health Needs
Functional Limitations
0 ADLs [Reference]
1 to 2 ADLs
3 or more ADLs
Diagnosed Conditions

Economic Access

>200% of FPL [Reference]
High school education or GED
Predisposing

Age
65 to 74 years [Reference]

Constant
Log Likelihood
Number of observations

-115.966
367

Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the
.10 level
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Conversely, older adults reporting no functional difficulties
should have little need for prescription drugs, rendering the
impact of Medicare Part D coverage minimal at best.

Results
Table 1 presents logit coefficients, standard errors, and the
odds (exp(B)) of Medicare Part D enrollment from a logistic
regression model examining the determinants of the enrollment decision. Among the two sets of health-related measures,
the model reveals that functional limitations and heart disease
are significantly associated with the enrollment decision. More
specifically, individuals with 1 to 2 ADL difficulties are more
than three times as likely as those with 0 ADL difficulties to
enroll in Medicare Part-D, while those with heart disease
are nearly twice as likely to enroll in the program relative to
those without heart disease, thus lending some credence to the
notion that Medicare Part D enrollees may indeed be sicker
than non-enrollees.
With respect to the economic access variables, the model
reveals that family income as measured by an income-to-poverty ratio is significantly associated with Medicare Part D enrollment. Individuals with family income less than or equal to
100% of federal poverty are more than two and one-half times
as likely to enroll in Part D relative to those with family income
greater than 200% of poverty. Stated differently, it appears that
Medicare Part D enrollees may not only be sicker but also
poorer relative to non-enrollees. Meanwhile, none of the predisposing characteristics were found to be significantly associated with Medicare Part D enrollment.
Table 2 presents logit coefficients, standard errors, and
the odds of prescription drug use, as well as ordinary least
squares (OLS) estimates and standard errors of the logarithm of monthly out-of-pocket drug expenses. The models
examine the extent to which the effect of Medicare prescription drug insurance coverage on prescription drug use and
costs differs across functional health status, and finds that
among individuals with 0 ADL difficulties, stand-alone Part
D coverage is significantly associated with 4.29 times greater
odds of prescription drug use. Among those with 1 to 2
ADL difficulties, stand-alone Part D coverage is significantly
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associated with nearly 6 times greater odds of prescription
drug use. Interestingly, stand-alone Part D coverage is not significantly associated with prescription drug use among those
with 3 or more ADL difficulties. This may be due to the financing structure built into the Part D program, that is, the co-insurance payments and coverage gaps (i.e., the donut hole) that
incentivize enrollees to either minimize annual drug costs or
claim catastrophic needs.
Table 2a. Logistic and OLS Regression Coefficients and Standard
Errors for Rx Drug Use and (log) Out-of-pocket Expenses
Logistic Regression of
Rx Drug Use

Health Needs
Functional Limitations and Prescription
Drug Insurance
0 ADLs | Employer

B(SE)

Exp(B)

OLS
Regression
of (Log)
Out-of-Pocket
Expenses
B(SE)

1.289(.252)***

3.627

-0.015(.130)

0 ADLs | Medicaid

1.098(.443)**

2.997

-0.674(.188)***

0 ADLs | Stand-Alone Part D

1.456(.265)***

4.290

0.167(.132)
-0.089(.130)

0 ADLs | Medicare Adv/Medigap/Other

1.234(.247)***

3.437

1 – 2 ADLs | Employer

1.427(.518)***

4.166

0.139(.170)

1 – 2 ADLs | Medicaid

1.437(.825)*

4.208

-0.479(.262)*

1 – 2 ADLs | Stand-Alone Part D

1.779(.667)***

5.923

0.276(.176)

1 – 2 ADLs | Medicare Adv/Medigap/Other

1.531(.460)***

4.621

0.202(.165)

 3 ADLs | Employer

1.585(1.015)

4.878

0.210(.251)

 3 ADLs | Medicaid

2.805(1.540)*

16.529

-0.387(.294)

 3 ADLs | Stand-Alone Part D
 3 ADLs | Medicare Adv/Medigap/Other

1.367(.998)

3.924

0.513(.267)*

2.808(1.179)**

16.576

0.456(.220)**

Diagnosed Conditions
High blood pressure

1.831(.154)**

6.243

0.114(.040)***

Diabetes

1.418(.285)**

4.129

0.199(.042)***

Cancer

0.268(.168)

1.308

-0.043(.052)

Lung disease

0.391(.227)*

1.478

0.158(.053)***

Heart disease

1.385(.231)***

3.994

0.198(.039)***

Stroke

0.844(.429)**

2.325

0.167(.066)**

Psychiatric

0.479(.190)**

1.614

0.104(.041)**

0.060(.114)

1.062

0.060(.039)

Arthritis

Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the
.10 level
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Moreover, individuals diagnosed with high blood pressure, diabetes, heart disease, and stroke are more than twice as
likely to use prescription drugs relative to those without these
conditions. With respect to predisposing factors, females and
married or partnered individuals are significantly more likely
to use prescription drugs. Surprisingly, none of the economic
access factors were found to be significantly associated with
prescription drug use.
Table 2b. Logistic and OLS Regression Coefficients and Standard
Errors for Rx Drug Use and (log) Out-of-pocket Expenses
Logistic Regression of Rx
Drug Use

OLS
Regression
of (Log)
Out-of-Pocket
Expenses

B(SE)

Exp(B)

B(SE)

0% to 100% of FPL

-0.166(.302)

.847

-0.167(.108)

101% to 200% of FPL

-0.006(.187)

.994

-0.044(.061)

-

-

0.262(.198)

1.299

-0.009(.068)
0.021(.050)

Economic Access
Family Income

>200% of FPL [Reference]
High school education or GED
Predisposing

0.375(.145)***

1.454

Hispanic

Female

-0.086(.329)

.918

0.028(.116)

Black

-0.322(.284)

.725

0.101(.097)

Married or partnered

0.262(.154)*

1.300

0.133(.053)**

Age
-

-

75 to 84 years

65 to 74 years [Reference]

0.144(.158)

1.155

0.061(.052)

85 years and over

0.396(.272)

1.485

-0.038(.081)

-1.125(.329)

.325

3.247(.154)

Constant
Log Likelihood
R Square
Number of observations

-732.069

-

-

0.076

8456

6316

Notes: ***Significant at the .01 level; **Significant at the .05 level; *Significant at the
.10 level

In the final OLS regression, the findings reveal that, surprisingly, Medicare prescription drug insurance coverage
bears little relation to out-of-pocket spending on prescription drugs. While Medicaid coverage appears to be significantly associated with lower out-of-pocket spending for
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individuals with either 0 or 1 to 2 ADL difficulties, stand-alone
Part D coverage is found to be significantly associated with
greater out-of-pocket spending on prescription drugs among
individuals with 3 or more ADL difficulties. Thus, while prior
studies have linked Medicare Part D coverage to lower prescription drug costs, and therefore, to increases in prescription
drug use, these findings suggest a rather glaring disconnect
in the effect of Medicare Part D coverage on prescription drug
use and costs.
Moreover and as one might expect, individuals diagnosed
with high blood pressure, diabetes, lung disease, heart disease,
stroke, and psychiatric conditions incur greater monthly outof-pocket expenses for prescription drugs relative to those
without such conditions. More specifically, monthly out-ofpocket expenses are in the range of 10.4% to 19.9% greater for
those with the aforementioned diagnosed conditions.
With respect to predisposing factors, out-of-pocket expenses are 13.3% higher for individuals who are married or partnered. And, as was the case for prescription drug use, none
of the economic access factors were found to be significantly
associated with the level of out-of-pocket spending.

Discussion
This research first examined the determinants of Medicare
Part D enrollment with the expectation that Medicare Part D
participants have poorer functional health relative to nonparticipants. The research then assessed whether and to what
extent Medicare Part D coverage moderates the impact of
functional health status on prescription drug use and costs.
While prior studies have used quasi-experimental designs
comparing Medicare eligible- to non-eligible (i.e., younger
than age 65) individuals to assess the impact of Medicare Part
D coverage on prescription drug use and costs, this research
relied on multivariate regression analyses to assess the impact
of Medicare Part D coverage within a sample of Part D eligible
older adults and across varying levels of functional health.
As such, logistic regression analyses first revealed that
Medicare Part D participants are systematically different from
nonparticipants in a number of important ways. As prior
studies have shown (Levy & Weir, 2010), individuals who enroll
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in Medicare Part D indeed have poorer (functional) health relative to nonparticipants, and thus, have greater demand for
prescription drugs. The analyses also revealed that Medicare
Part D participants tend to have the lowest income levels according to federal poverty standards. That is, Medicare Part
D participants likely use their Medicaid prescription drug insurance coverage to help pay for their Part D program benefits. In short, Medicare Part D participants are sicker and
poorer relative to nonparticipants. Stated differently, health
and income represent potentially powerful selection factors in
any observed relationship between Medicare Part D coverage
and prescription drug use which may remain unaccounted for
in research designs that do not allow for random assignment
into treatment and control conditions for practical or ethical
reasons.
Taking into consideration these prominent selection factors
and functional health status in particular, logistic and OLS regressions revealed that the effect of Medicare Part D coverage
on prescription drug use and costs is not as unambiguous as
previously believed. Clearly, Medicare Part D coverage is significantly associated with prescription drug use and costs, but
in a manner that likely reflects the financing structure of the
Medicare Part D program. For those with few health limitations, Medicare Part D coverage appears to have a negligible
impact in lowering costs, and yet, enrollees are still more likely
to use prescription drugs. For those with the most health limitations, Medicare Part D coverage is significantly associated
with greater out-of-pocket spending on prescription drugs,
and hence, such enrollees are not significantly more likely to
use prescription drugs. Stated differently, while prior studies
have compared Medicare eligible- to non-eligible individuals to find that Medicare Part D coverage significantly lowers
out-of-pocket costs, and therefore, increases prescription drug
use, this study compared Medicare Part D enrollees to ageeligible non-enrollees to generate findings that imply that the
presumed effect of Medicare Part D coverage on prescription
drug use may be spurious.
While the findings may seem somewhat counterintuitive,
they are arguably consistent with the Medicare Part D financing structure and the coverage gaps that are inherent in the
program. That is, individuals with the fewest health needs
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may be incentivized to minimize their prescription drug use
due to the deductibles and a significant coverage gap for
annual prescription drug costs that reach moderate levels (i.e.,
the “doughnut hole”), while individuals with the most health
needs may be incentivized to claim catastrophic benefits, particularly if their annual prescription drug costs fall within the
doughnut hole.
Future research on prescription drug use among older
adults might consider examining the impact of Medicare
Part D coverage not only across varying levels of functional
health but across varying levels of income. As shown above,
Medicare Part D participants are not only sicker than nonparticipants but they also exhibit lower levels of income. Hence,
it would be interesting to consider how selection factors other
than health impact the use of prescription drugs and associated costs. Future research could also entertain the possibility of
incorporating policy-relevant cutoffs in terms of annual (total)
prescription drug costs if such data becomes available. This
would be with an eye towards improving upon previously developed measures of the demand for prescription drugs (see
Levy & Weir, 2009). In addition, with the implementation of
the Affordable Care Act (ACA) provisions that gradually close
the existing coverage gaps in prescription drug use and spending, it becomes almost imperative that this study is revisited
after full implementation of ACA to see whether the differential impacts of Medicare Part D coverage across varying levels
of functional health still hold.
While increasing access to prescription drug insurance
coverage was not necessarily one of the prominent goals of
the recent health care reform, implicit in the goal of expanding access to health insurance coverage more broadly among
previously uninsured individuals is that this greater access
to health insurance will necessarily lead to greater access to
health service use in its various forms. Thus, the findings
generated by this research provide evidence that while older
adults across the health spectrum seem to be benefiting from
greater access to prescription drugs, this greater access is probably not attributable to the lowering of prescription drug costs
vis-à-vis the Medicare prescription drug benefit program, as
prior research on prescription drug use has assumed to be the
case. Hence, policy advocates who champion greater access to
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health insurance and care should note that current advocacy
efforts in this realm may be best directed at ensuring that the
existing coverage gaps in government-sponsored prescription
drug plans are indeed continually addressed.
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Appendix: Baseline Characteristics of Sample Members by
Prescription Drug Insurance Coverage and Prescription Drug Use
Table A1 below describes the baseline characteristics of sample
members by type of prescription drug insurance coverage in 2010.
The columns represent five different prescription drug insurance
options reported in the study. With respect to the number of
functional limitations, sample members who report Stand-Alone
Part D coverage are not different from those without prescription
drug insurance coverage. While they appear to be no different
in terms of their functional health, they are more likely to be
diagnosed with high blood pressure (76% v. 60%), diabetes (28% v.
17%), cancer (21% v. 17%), lung disease (15% v. 10%), heart disease
(36% v. 29%), psychiatric conditions (19% v. 15%), and arthritis (79%
v. 65%) relative to those without coverage.
With respect to the economic access variables, sample members
with Part D coverage are different from those without prescription
drug insurance coverage both in terms of family income and
educational attainment. They are less likely to be poor (7% vs. 10%)
and more likely to have a high school education or GED (81% vs.
77%) relative to those without coverage.
As for predisposing characteristics, sample members with Part D
coverage are less likely to be Hispanic and Black, and more likely to
be female and married or partnered as compared to those without
coverage. They are also generally younger relative to those without
coverage.
Table A2 below describes the baseline characteristics of sample
members by prescription drug use in 2012. Sample members
who report regularly using prescription drugs are reported
under one column, while those who report not using prescription
drugs regularly are reported under a separate column. Among
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sample members with 0 ADL difficulties, those who regularly use
prescription drugs are more likely to be covered under stand-alone
Part D relative to those who do not use prescription drugs (21% v.
18%). Among sample members with 1 to 2 ADL difficulties, only
3% of those who regularly use prescription drugs have standalone Part D coverage as compared to 1% for those who do not
use prescription drugs. Among sample members with 3 or more
ADL difficulties, there is no apparent difference in stand-alone Part
D coverage between those who regularly use prescription drugs
relative to those who do not use prescription drugs.
Moreover, sample members who regularly use prescription drugs
are more likely to be diagnosed with high blood pressure (79% v.
25%), diabetes (31% v. 6%), cancer (21% v. 17%), lung disease (15%
v. 7%), heart disease (38% v. 9%), stroke (11% v. 2%), psychiatric
conditions (21% v. 8%), and arthritis (79% v. 64%) relative to those
who do not use prescription drugs. They are also somewhat more
likely to be female, Black, and married or partnered as compared to
those who do not use prescription drugs.
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Table A1. Sample Characteristics by Prescription Drug Insurance Coverage in 2010

Employer

Medicaid

Stand-Alone
Part D

Medicare
Advantage/
Medigap/
Other

None

Total

Prescription Drug Insurance Coverage

0 ADLs

0.84

0.60

0.83

0.81

0.83

0.81

1 to 2 ADLs

0.12

0.23

0.12

0.14

0.13

0.14

3 or more ADLs

0.04

0.17

0.05

0.05

0.05

0.05

High blood pressure

0.73

0.87

0.76

0.72

0.60

0.74

Diabetes

0.28

0.42

0.28

0.27

0.17

0.29

Cancer

0.23

0.16

0.21

0.21

0.17

0.21

Lung disease

0.15

0.21

0.15

0.13

0.10

0.15

Heart disease

0.35

0.45

0.36

0.35

0.29

0.36

Stroke

0.11

0.17

0.10

0.09

0.09

0.10

Psychiatric

0.20

0.35

0.19

0.19

0.15

0.20

Arthritis

0.77

0.82

0.79

0.77

0.65

0.77

0% to 100% of FPL

0.04

0.43

0.07

0.07

0.10

0.09

101% to 200% of FPL

0.15

0.35

0.25

0.26

0.29

0.23

>200% of FPL

0.81

0.22

0.68

0.67

0.60

0.68

0.88

0.40

0.81

0.78

0.77

0.79

Female

0.54

0.69

0.63

0.58

0.54

0.59

Hispanic

0.04

0.33

0.05

0.10

0.07

0.09

Black

0.12

0.33

0.10

0.12

0.13

0.13

Married or partnered

0.68

0.31

0.60

0.62

0.55

0.60

65 to 74 years

0.52

0.48

0.53

0.52

0.49

0.52

75 to 84 years

0.38

0.38

0.37

0.36

0.34

0.37

85 years and over

0.10

0.14

0.10

0.12

0.17

0.11

2581

652

2105

2751

367

8456

Health Needs
Functional Limitations

Diagnosed Conditions

Economic Access
Family Income

High school education or GED
Predisposing

Age

Number of observations

184			

Journal of Sociology & Social Welfare

Table A2. Sample Characteristics by Prescription Drug Use in 2012
Prescription Drug Use
Rx
Drug
Use
Health Needs
Functional Limitations & Prescription Drug
Insurance
0 ADLs | Employer

No Rx
Drug
Use

Total

0.26

0.25

0.26

0 ADLs | Medicaid

0.05

0.04

0.05

0 ADLs | Stand-Alone Part D

0.21

0.18

0.21

0 ADLs | Medicare Adv/Medigap/Other

0.26

0.30

0.26

1 – 2 ADLs | Employer

0.04

0.02

0.04

1 – 2 ADLs | Medicaid

0.02

0.01

0.02

1 – 2 ADLs | Stand-Alone Part D

0.03

0.01

0.03

1 – 2 ADLs | Medicare Adv/Medigap/Other

0.05

0.03

0.05

 3 ADLs | Employer

0.01

0.01

0.01

 3 ADLs | Medicaid

0.01

0.00

0.01

 3 ADLs | Stand-Alone Part D

0.01

0.01

0.01

 3 ADLs | Medicare Adv/Medigap/Other

0.02

0.01

0.02

High blood pressure

0.79

0.25

0.74

Diabetes

0.31

0.06

0.29

Cancer

0.21

0.17

0.21

Lung disease

0.15

0.07

0.15

Heart disease

0.38

0.09

0.36

Stroke

0.11

0.02

0.10

Psychiatric

0.21

0.08

0.20

Arthritis
Economic Access
Family Income

0.79

0.64

0.77

0% to 100% of FPL

0.09

0.08

0.09

101% to 200% of FPL

0.23

0.21

0.23

>200% of FPL

0.68

0.70

0.68

0.79

0.79

0.79

Female

0.59

0.56

0.59

Hispanic

0.09

0.08

0.09

Black

0.13

0.11

0.13

Married or partnered

0.61

0.59

0.60

65 to 74 years

0.51

0.56

0.52

75 to 84 years

0.37

0.08

0.37

85 years and over

0.12

0.11

0.11

7750

706

8456

Diagnosed Conditions

High school education or GED
Predisposing

Age

Number of observations

